-
Don’t Miss: Infinity Pharmaceuticals (NASDAQ:INFI), Netflix (NASDAQ:NFLX), Fifth Street Finance Corp. (NASDAQ:FSC), News Corporation (NASDAQ:NWSA), VirnetX Holding Corp (NYSEMKT:VHC)
On Thursday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $12.25. Company’s sales growth for last 5 years was 26.60%. Equities researchers at Deutsche Bank assumed coverage on shares of Infinity Pharmaceuticals (NASDAQ:INFI) in a research report issued on Wednesday, TheFlyOnTheWall.com reports. The firm set a “buy” rating and a $20.00 price target on the…
-
Stock Runners: Leju Holdings Limited (NYSE:LEJU), Comstock Resources Inc. (NYSE:CRK), BlackBerry Ltd (NASDAQ:BBRY), Infinity Pharmaceuticals (NASDAQ:INFI), Bio-Rad Laboratories (NYSE:BIO)
On Thursday shares of Leju Holdings Limited (NYSE:LEJU) closed at $10.53. Leju Holdings Limited (NYSE: LEJU) announced that it filed its annual report on Form 20-F for the fiscal year ended December 31, 2014 with the Securities and Exchange Commission on April 21, 2015. Comstock Resources Inc. (NYSE:CRK) in last trading activity moved up 5.29%…
-
Stocks to Watch: Infinity Pharmaceuticals (NASDAQ:INFI), Exxon Mobil Corporation (NYSE:XOM), Perfect World Co., (NASDAQ:PWRD), Renren (NYSE:RENN), American Eagle Energy (NYSEMKT:AMZG)
On Tuesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $15.00. Company’s sales growth for last 5 years was 26.60% and EPS growth for next 5 years is recorded as 3.00%. Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced that Sujay Kango has joined the company as executive vice president, chief commercial officer and Winston “K.C.” Lam has…
-
Stocks in Focus: ANI Pharmaceuticals (NASDAQ:ANIP), E-House (China) Holdings (NYSE:EJ), Broadway Financial Corporation (NASDAQ:BYFC), General Moly (NYSEMKT:GMO), Infinity Pharmaceuticals (NASDAQ:INFI)
On Wednesday shares of ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) closed at $69.71. Company’s sales growth for last 5 years was 112.30% and EPS growth for next 5 years is recorded as 21.80%. ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) will present on April 14, 2015 at Needham & Company’s 14th Annual Healthcare Conference at the Westin Grand Central Hotel…
-
Big Movers: Infinity Pharmaceuticals (NASDAQ:INFI), Revance Therapeutics (NASDAQ:RVNC), Delta Air Lines (NYSE:DAL), Methes Energies International (NASDAQ:MEIL), Cisco Systems (NASDAQ:CSCO)
On Tuesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $13.98. Company’s sales growth for last 5 years was 26.60% and EPS growth for next 5 years is recorded as 3.00%. Analysts at TheStreet downgraded shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) from a “hold” rating to a “sell” rating in a research note. Revance Therapeutics,…
-
Top Stories: Infinity Pharmaceuticals (NASDAQ:INFI), ICICI Bank (NYSE:IBN), Ryanair Holdings plc (NASDAQ:RYAAY), CLARCOR Inc. (NYSE:CLC), QUALCOMM (NASDAQ:QCOM)
On Tuesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $15.75. Company’s sales growth for last 5 years was 26.60% and EPS growth for next 5 years is recorded as 3.00%. Analysts at TheStreet downgraded shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) from a “hold” rating to a “sell” rating in a research note. ICICI Bank…
-
Investors Watch List: Tiger Media (NYSEMKT:IDI), Facebook Inc (NASDAQ:FB), Infinity Pharmaceuticals (NASDAQ:INFI), Abaxis (NASDAQ:ABAX), ViaSat Inc. (NASDAQ:VSAT)
On Friday shares of Tiger Media, Inc. (NYSEMKT:IDI) closed at $6.05. Company’s sales growth for last 5 years was -41.30%. Tiger Media, Inc. (NYSEMKT:IDI), announced that the previously approved reverse stock split of the Company’s ordinary shares, par value $0.0001 per share, at a ratio of one-for-five (the “Stock Split”), became effective after the close…
-
Mix Sector Stocks News: Infinity Pharmaceuticals (NASDAQ:INFI), CollabRx (NASDAQ:CLRX), Egalet Corporation (NASDAQ:EGLT), Hewlett-Packard Company (NYSE:HPQ), ConocoPhillips (NYSE:COP)
Infinity Pharmaceuticals Inc. (NASDAQ:INFI) expects to report topline data from DYNAMO, a phase 2 study of Duvelisib in patients with refractory indolent non-Hodgkin lymphoma, in the second half of 2015. The study is scheduled to complete patient enrollment in the first half of the year. On Friday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at…
-
Stock Alert: Infinity Pharmaceuticals (NASDAQ:INFI), Cablevision Systems Corporation (NYSE:CVC), Micrel Inc. (NASDAQ:MCRL), G&K Services Inc. (NASDAQ:GK), Penn Virginia Corporation (NYSE:PVA)
Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) announced Net loss for full-year 2014 was $17.4 million, or a basic and diluted loss per common share of $0.36, compared to $126.8 million, or a basic and diluted loss per common share of $2.64 for 2013.On Wednesday shares of Infinity Pharmaceuticals, Inc. (NASDAQ:INFI) closed at $15.12. Company’s EPS growth for…